Molecular Partners AG operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Molecular Partners AG with three other miscellaneous service companies in Europe: GeNeuro SA of France (2017 sales of 14.95 million Euro [US$18.50 million] ), Selvita SA of Poland (67.54 million Polish New Zlotys [US$20.06 million] of which 65% was Services), and Zealand Pharma A/S which is based in Denmark (139.78 million Danish Kroner [US$23.22 million] of which 100% was Biopharmaceuticals).

Sales Analysis.